Auna (NYSE:AUNA – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.11), FiscalAI reports. The company had revenue of $362.85 million during the quarter, compared to the consensus estimate of $357.39 million. Auna had a return on equity of 13.32% and a net margin of 0.44%.
Auna Price Performance
Shares of NYSE AUNA opened at $5.42 on Thursday. Auna has a 1 year low of $4.09 and a 1 year high of $6.85. The company has a debt-to-equity ratio of 1.76, a current ratio of 1.09 and a quick ratio of 1.00. The company’s 50-day moving average is $5.17 and its 200 day moving average is $5.11. The stock has a market capitalization of $401.13 million, a P/E ratio of 77.44 and a beta of 0.61.
Insider Activity at Auna
In other Auna news, Director John Wilton sold 17,574 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $4.17, for a total transaction of $73,283.58. Following the completion of the transaction, the director owned 49,974 shares of the company’s stock, valued at approximately $208,391.58. This trade represents a 26.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, President Leon Jesus Zamora acquired 30,000 shares of Auna stock in a transaction that occurred on Tuesday, May 26th. The shares were bought at an average cost of $4.39 per share, with a total value of $131,700.00. Following the transaction, the president owned 45,914 shares in the company, valued at $201,562.46. This represents a 188.51% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders bought a total of 77,640 shares of company stock valued at $331,539 in the last three months.
Hedge Funds Weigh In On Auna
Wall Street Analyst Weigh In
A number of research analysts recently commented on AUNA shares. Wall Street Zen cut Auna from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 5th. JPMorgan Chase & Co. reduced their price objective on Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 26th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Auna in a report on Wednesday, June 24th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $6.97.
Read Our Latest Report on Auna
Auna Company Profile
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
Read More
- Five stocks we like better than Auna
- Diamondback Hits a Milestone at Just the Right Time
- Analog Devices’ AI Pivot Could Push Shares to Fresh Highs
- One Platform, Every Ailment: Hinge Health’s Gamble
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
